No Barriers, Wells Fargo Select 2019 Global Impact Challenge Winners

    NEXT STORY
    Spero Therapeutics Receives FDA Orphan Drug Designation for SPR720 for the Treatment of Nontuberculous Mycobacterial (NTM) Infection
    PREV STORY
    LexaGene Provides Corporate Update
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    CRISPR Therapeutics to Participate in Upcoming Investor Conferences

    author_avatar
    NASDAQ Market News

    Saniona AB: Saniona medverkar i bolagsbildningen av Scandion Oncology och knoppar av kliniskt program och relaterad jonkanalsplattform

    PRESSMEDDELANDE 3 MAJ, 2017 Saniona, ett ledande bioteknikbolag inom jonkanaler, meddelar idag att bolaget ...

    author_avatar
    NASDAQ Market News

    Ayala Pharmaceuticals Announces Pricing of Initial Public Offering

    author_avatar
    NASDAQ Market News